Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 4NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neoplasms, Plasma Cell 1Multiple Myeloma 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia 1Breast Neoplasms 1

Interventions

Cytarabine 14Daunorubicin 8Gemtuzumab 7sargramostim 5Gene Expression Profiling 5Flow Cytometry 5Filgrastim 5Mitoxantrone 4Idarubicin 4Etoposide 4Clofarabine 3Polymerase Chain Reaction 2Peripheral Blood Stem Cell Transplantation 2Observation 2Immunologic Techniques 2DNA Methylation 2zosuquidar trihydrochloride 1valspodar 1fludarabine phosphate 1etoposide phosphate 1Topotecan 1Thiotepa 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy 1Pharmacogenomic Testing 1Microarray Analysis 1Methotrexate 1Mass Spectrometry 1Granulocyte Colony-Stimulating Factor 1Fluconazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Leukemia, Myelomonocytic, Acute × valspodar × Clear all
NCT00004217 2015-03-06

S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

SWOG Cancer Research Network

Phase 2 Completed
55 enrolled
Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡